Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Actuate Therapeutics, Inc. (ACTU) had Operating Cash Flow per Share of $-0.91 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-22.23M |
|
-- |
|
-- |
|
$22.50M |
|
$-22.50M |
|
$0.27M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.50M |
|
$-22.50M |
|
21.02M |
|
21.02M |
|
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$13.64M |
|
-- |
|
$0.39M |
|
$14.04M |
|
$5.71M |
|
-- |
|
$0.41M |
|
$6.11M |
|
$7.92M |
|
$7.92M |
|
$7.92M |
|
23.25M |
|
| Cash Flow Statement Financials | |
$-19.21M |
|
-- |
|
$23.72M |
|
$8.64M |
|
$13.16M |
|
$4.52M |
|
$6.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-280.51% |
|
-280.51% |
|
-158.36% |
|
-280.51% |
|
$0.34 |
|
$-0.91 |
|
|
Operating Cash Flow per Share |
$-0.91 |